ZIMMER BIOMET HOLDINGS, INC. FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $8.2B |
| Gross margin | 69.7% |
| Operating income | $1.1B |
| Net income | $705.1M |
| Diluted EPS | $3.55 |
| Cash & equivalents | $591.9M |
| Total assets | $23.1B |
| Long-term debt | $6.9B |
Key takeaway
Zimmer Biomet reported $8.23 billion in revenue for 2025 with a 69.7% gross margin and $705.1 million in net income, translating to diluted EPS of $3.55.
🔒 4 more takeaways in the full analysis
Beneath the surface
Net debt is significantly larger than the headline $6.93B long-term debt figure suggests once total indebtedness of $7.5B is compared against only $591.9M of cash, implying net debt of roughly $6.9 billion.
🔒 3 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for ZBH.
Read the full analysis free Free account · 5 full analyses included · no card required